Scientists at Seattle’s Fred Hutchinson Cancer Research Center have figured out how to use venom from the Israeli deathstalker scorpion to “light up”… Read More
Seattle-based Juno Therapeutics has acquired RedoxTherapies for $10 million, to secure exclusive rights to a molecule that may provide a new… Read More
Commercial partners can help non-profits, like the Fred Hutchinson Cancer Research Center, bring life-saving treatments to patients faster. That’s why… Read More
A quarter-century after her discovery of the BRCA1 breast cancer gene, University of Washington geneticist Mary-Claire King has received the nation’s… Read More